Abstract:Background: The 16p11.2 deletion is one of the most common genetic aetiologies of neurodevelopmental disorders (NDDs). The prenatal phenotype of 16p11.2 deletion and the potential mechanism associated with postnatal clinical manifestations were largely unknow. We revealed the developmental trajectories of 16p11.2 deletion from the prenatal to postnatal periods and to identify key signaling pathways and candidate genes contributing to neurodevelopmental abnormalities. Methods: In this 5-y retrospective cohort study, women with singleton pregnancies who underwent amniocentesis for chromosomal abnormalities were included. Test of copy-number variations (CNVs) involved single nucleotide polymorphism-array and CNV-seq was performed to detected 16p11.2 deletion. For infants born carrying the 16p11.2 deletion, neurological and intellectual evaluations using the Chinese version of the Gesell Development Scale. For patients observed to have vertebral malformations, Sanger sequencing for T-C-A haplotype of TBX6 was performed. For those infants with clinical manifestations, whole-exome sequencing was consecutively performed in trios to rule out single-gene diseases, and transcriptomics combined with untargeted metabolomics were performed. Results: The prevalence of 16p11.2 deletion was 0.063% (55/86,035) in the prenatal period. Up to 80% (20/25) of the 16p11.2 deletions were proven de novo by parental confirmation. Approximately half of 16p11.2 deletions (28/55) were detected with prenatal abnormal ultrasound findings. Vertebral malformations were identified as the most distinctive structural malformations and were enriched in fetuses with 16p11.2 deletions compared with controls (90.9‰ [5/55] vs. 8.4‰ [72/85,980]; P < 0.001). All 5 fetuses with vertebral malformations were confirmed to have the TBX6 haplotype of T-C-A. Overall, 47.6% (10/21) infants birthed were diagnosed with NDDs of different degrees. Language impairment was the predominant manifestation (7/10; 70.0%), followed by motor delay (5/10; 50%). Multi-omics analysis indicated that MAPK3 was the central hub of the differentially expressed gene (DEG) network. We firstly reported that histidine-associated metabolism may be the core metabolic pathway related to the 16p11.2 deletion. Conclusion: We demonstrated the prenatal presentation, incomplete penetrance and variable expressivity of the 16p11.2 deletion. We identified vertebral malformations were the most distinctive prenatal phenotypes, and language impairment was the predominant postnatal manifestation. Most of the 16p11.2 deletion was de novo. Meanwhile, we suggested that MAPK3 and histidine-associated metabolism may contribute to neurodevelopmental abnormalities of 16p11.2 deletion.

One case of chromosome 16p11. 2 deletion syndrome and literature review

Cognitive and behavioral characterization of 16p11.2 deletion syndrome.

Clinical phenotype of the 16p.13.11 microdeletion: a case report with a mini review of the literature

Chromosome 16p13.11 Microdeletion Syndrome in a Newborn: A Case Study

Diversity of Clinical and Molecular Characteristics in Korean Patients with 16p11.2 Microdeletion Syndrome

A Rare Case of Trisomy 11Q23.3-11Q25 and Trisomy 22Q11.1-22Q11.21

Molecular cytogenetic characterization of 16p11.2 microdeletions with diverse prenatal phenotypes: Four cases report and literature review

Chromosome 10q26 deletion syndrome: Two new cases and a review of the literature

Special clinical entity with 15q26 deletion: a novel case report

18Q22.1-Qter Deletion and 4p16.3 Microduplication in a Boy with Speech Delay and Mental Retardation: Case Report and Review of the Literature

Clinical and genetic study of a child with mental retardation and multiple congenital anomalies and a 16p13.11 microdeletion

[Clinical phenotype and genetic analysis of a rare case with 6p duplication and terminal deletion syndrome]

[Clinical phenotypes and genetic study of 2 cases with 22q13 deletion syndrome].

Analysis of the Clinical Phenotype in 20 Children with 22q11.2 Deletion Syndrome

Interstitial Deletion of the Short Arm of Chromosome 12 Confirmed by Oligonucleotide Array-Based Comparative Genomic Hybridization: A Case Report and Review of the Literature

Molecular Genetic and Clinical Characteristics of Fetuses With Chromosome 16 Short‐Arm Microdeletions/Microduplications

[Clinical and Genetic Analysis of a Fetus with 17q12 Microdeletion Syndrome].

Array CGH-based Detection and Characterization of Combined 1p36 Deletion and 22q13 Duplication in a Boy and a Fetus from a Single Family

Microdeletion of 4p16.2 in Children: A Case Report and Literature Review

Correlation between chromosome deletion and phenotypes in two cases of ring chromosome 6 syndrome

Prenatal prevalence and postnatal manifestations of 16p11.2 deletions: A new insights into neurodevelopmental disorders based on clinical investigations combined with multi-omics analysis